The overall trajectory for healthcare ETFs remains positive, fueled by factors such as an aging population, increased demand for healthcare services, and technological advancements. Given this positive sentiment, adding healthcare ETFs such as iShares Biotechnology ETF (IBB), SPDR S&P Health Care Equipment ETF (XHE), and iShares U.S. Medical Devices ETF (IHI) might be optimal defensive investing.
The rising need for personalized medication, along with the growing adoption of biotechnology in stem cell research and cloning techniques to replace damaged cells and tissues in regenerative medicines, is primarily driving the global biotechnology market.
